ReviewPreventive medicine2019
A review of tobacco regulatory science research on vulnerable populations.
Review in Preventive medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 27 citations in OpenAlex.
- Communicating the benefits of quitting smoking on mental health increases motivation to quit in people with anxiety and/or depression.Addictive behaviors · 2024Trial
- Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials.JAMA network open · 2020Trial
- Integration of community-engaged research technology and methods to guide tobacco regulatory science in rural communities.Frontiers in public health · 2026Article
- Cigarette smoking prevalence, nicotine dependence, and quit ratios among U.S. adult females by residence and military-veteran status: 2002-2023.Preventive medicine · 2025Article
- Age, cumulative psychosocial risk factors, and health disparities in U.S. adult cigarette smoking: 2002-2019.BMC medicine · 2025Article
- Unequal Impact of Flavored Tobacco Across Populations: From Neuroscience to Policy.Basic and clinical neuroscience · 2025Review
- Cigarettes and e-cigarettes use among US adults with multimorbidity.Drug and alcohol dependence reports · 2024Article
- Use of Machine Learning Tools in Evidence Synthesis of Tobacco Use Among Sexual and Gender Diverse Populations: Algorithm Development and Validation.JMIR formative research · 2024Article
- Disparities in Cigarette, E-cigarette, Cigar, and Smokeless Tobacco Use at the Intersection of Multiple Social Identities in the US Adult Population. Results From the Tobacco Use Supplement to the Current Population Survey 2018-2019 Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Relating individual differences in the reinforcing value of smoking and dependence severity to nicotine exposure levels in vulnerable populations.Preventive medicine · 2022Article
- Using an experimental tobacco marketplace to pilot test the substitutability of JUUL e-cigarettes and other alternative nicotine and tobacco products for conventional cigarettes among vulnerable populations.Preventive medicine · 2022Article
- Tobacco prevention and control interventions in humanitarian settings: a scoping review protocol.BMJ open · 2022Article
- Geographic isolation predicts tobacco product use among youth: A latent class analysis.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022Article
- Sociodemographic differences in young adults' recall of tobacco and cannabis marketing online and in television/film.Preventive medicine reports · 2021Article
- Cumulative disadvantage as a framework for understanding rural tobacco use disparities.Experimental and clinical psychopharmacology · 2021Review
- Behavioral economic measurement of cigarette demand: A descriptive review of published approaches to the cigarette purchase task.Experimental and clinical psychopharmacology · 2020Review
- Relating individual differences in nicotine dependence severity to underpinning motivational and pharmacological processes among smokers from vulnerable populations.Preventive medicine · 2020Article
- Behavior change, health, and health disparities 2020: Some current challenges in tobacco control and regulatory science.Preventive medicine · 2020Article
- Comparing participant estimated demand intensity on the cigarette Purchase Task to consumption when usual-brand cigarettes were provided free.Preventive medicine · 2020Article
- Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.Experimental and clinical psychopharmacology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 7 institutions in 2 countries.
Funding
Abstract
In 2013 the U.S. Food and Drug Administration and National Institutes of Health established fourteen Tobacco Centers of Regulatory Science (TCORS) to advance scientific knowledge relevant to conducting evidence-based tobacco regulation. This report reviews TCORS-funded research with adult vulnerable populations. The literature search included a list of all TCORS-funded publications compiled by the TCORS coordinating center; all TCORS were requested to share publications not in the coordinating-center's list. Only TCORS-funded reports describing an empirical study with an adult vulnerable population published in a peer-reviewed journal between September 2013 and June 2018 were included. 71 reports met inclusion criteria; 39% (28/71) examined tobacco use among those with mental health and medical comorbidities, 34% (24/71) socioeconomic disadvantage, 31% (22/71) women of reproductive age, 30% (21/71) racial/ethnic minorities, 18% (13/71) rural residents, and 3% (2/71) each among active military/veterans and sexual/gender minorities. Regarding scientific domains, 63% (45/71) investigated behavior, 37% (26/71) addiction, 24% (17/71) health effects, 20% (14/71) impact analyses, 18% (13/71) toxicity, 8% (6/71) marketing influences, and 7% (5/71) communications. Totals exceed 100% because some reports addressed multiple populations/domains. TCORS funding has generated a substantial, multidisciplinary body of new scientific knowledge on tobacco use in adult vulnerable populations. However, considerable variability was noted in the amount of research conducted across the various vulnerable populations and scientific domains. Most notably, relatively few studies focused on active military/veterans or sexual/gender minorities, and the scientific domains of marketing influences and communications were conspicuously underrepresented. These are important knowledge gaps to address going forward.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.